DEA Under Scrutiny: Report Alleges Failures in Cannabis Safety Oversight and Pharmaceutical Research Blockades
A recent report published via ACCESS Newswire on Morningstar on July 4, 2025, has ignited debate regarding the effectiveness of the Drug Enforcement Administration (DEA) in managing the complex landscape of cannabis regulation in the United States. The report levels significant criticism against the agency and, specifically, its Deputy Administrator Thomas Prevoznik, who heads the…